PMC:7228307 / 4315-4532 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"48","span":{"begin":156,"end":160},"obj":"Gene"}],"attributes":[{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"Gene:2213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"utic mAbs powerfully exploit these opposing activities, making them versatile drugs whose therapeutic potency can be improved by specific engineering of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T47","span":{"begin":44,"end":54},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T48","span":{"begin":153,"end":155},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T49","span":{"begin":156,"end":158},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"utic mAbs powerfully exploit these opposing activities, making them versatile drugs whose therapeutic potency can be improved by specific engineering of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":78,"end":83},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"utic mAbs powerfully exploit these opposing activities, making them versatile drugs whose therapeutic potency can be improved by specific engineering of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying "}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"48","span":{"begin":156,"end":160},"obj":"Gene"}],"attributes":[{"id":"A48","pred":"pubann:denotes","subj":"48","obj":"Gene:2213"}],"text":"utic mAbs powerfully exploit these opposing activities, making them versatile drugs whose therapeutic potency can be improved by specific engineering of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying "}